Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome

Shock

Volumn 6, Issue 2, 1996, Pages 142-149

  Quinn, James V ^a   Bilgrami, Sajad ^a   Seidel, Geoffrey J ^a   Slotman, Gus J ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ICOSANOID; LEUKOTRIENE; THROMBOXANE B2;

ADULT; ANALYTICAL EQUIPMENT; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; ANIMALS; EICOSANOIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FEMALE; HUMANS; LEUKOTRIENES; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOXANE B2;

EID: 0030202513     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199608000-00010     Document Type: Review

References (31)

1. Cook JA, Geisel J, Halushka PV, Reines HD: Prostaglandins, thromboxanes, leukotrienes, and cytochrome p-450 metabolites of arachidonic acid. New Horizons 1:60-69, 1993.
2. Slotman GJ, Quinn JV, Burchard KW, Gann DS: Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock. Circ Shock 16:395-404, 1985.
3. 2, and 11-6 in a porcine model of recurrent endotoxemia. Circ Shock 35:237-244, 1991.
4. 2. Anal Lett 9:611-627, 1976.
5. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN: Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237:1171-1176, 1987.
6. 4 in thermally injured patients' plasma and bum blister fluid. JBCR 8:189-191, 1987.
7. Coggeshall JW, Christman BW, Lefferts PL, Serafin WE, Blair IA, Butterfield MJ, Snapper JR: Effect of inhibition of 5-lipoxygenase metabolism of arachidonic acid on response to endotoxemia in sheep. J Appl Physiol 65:1351-1359, 1988.
8. 4 synthesis and diapedesis. Surgery 111:287-293, 1992.
9. 9 Klausner JM, Paterson IS, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Leukotrienes, but not complement, mediate limb ischemia-induced lung injury. Ann Surg 209:462-470, 1989.
10. Salmon JA: Analysis of cyclo-oxygenase and lipoxygenase products in inflammatory exudate. Prostaglandins 27:364-366, 1984.
11. Miller DK, Sadowski S, DeSousa D, Maycock AL, Lombardo DL, Young RN, Hayes EC: Development of enzyme-linked immunosorbant assays for measurement of leukotrienes and prostaglandins. J Immunol Methods 81:169-185, 1985.
12. Wright PF, Nilsson E, Vanrooij EMA, Lelenta M, Jeggo MH: Standardization and validation of enzyme-linked immunosorbant assay techniques for the detection of antibody in infectious disease diagnosis. Rev Sci Tech 12:435-450,1993.
13. Maciel RJ: Standard curve fitting in immunodiagnostics: A primer. J Clin Immunol 8:98-105, 1985.
14. Karpinski KF: Optimality assessment in the enzyme-linked immunosorbant assay (ELISA). Biometrics 46:381-390, 1990.
15. Bone RC, Fisher CJ, Clemmer TJ, Metz CA, Slotman GJ: Sepsis syndrome, a valid clinical entity. Crit Care Med 17:389-393, 1989.
16. 2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. Surgery 100:214-221, 1986.
17. 4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model. Crit Care Med 21:1825-1837, 1993.
18. Granstrom E, Kindahl H: Radioimmunoassay of prostaglandins and thromboxanes. In Frolich JC (ed): Advances in Prostaglandin and Thromboxane Research. New York NY: Raven Press, 1978, pp 119-210.
19. Lelcuk S, Huval WV, Valeri CR, Shepro D, Hechtman HB: Inhibition of ischemia-induced thromboxane synthesis in man. J Trauma 24:393-396, 1984.
20. Hayes EC, Lombardo DL, Girard Y, et al: Measuring leukotrienes of slow reacting substance of anaphylaxis: Development of a specific radioimmunoassay. J Immunol 131:429-433, 1983.
21. Ekins R: Immunoassay design and optimization. In Price CP, Newman DJ (eds): Principles and Practices of Immunoassay. New York, NY: Stockton Press, 1991, pp 96-53.
22. Docherty JC, Gerrard JM: An enzyme-linked immunosorbant assay for 6-keto PGF-1alpha. Prostaglandins 31:375-383, 1986.
23. 2 and 6-oxo-PGF1 alpha usingperoxidase as label. Biomed Biochem Acta 47:5137-5139, 1988.
24. Pradelles P, Grassi J, Maclouf J: Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to Radioimmunoassay. Anal Chem 57:1170-1173, 1985.
25. Baxendale PM, Martin RC, Hughes KT, Lee DY, Waters NM: Development of scintillation proximity assays for prostaglandins and related compounds. In Samuelsson B (ed): Advances in Prostaglandins, Thromboxane, and Leukotriene Research. New York NY: Raven Press, 1990, pp 303-306.
26. Bunch DS, Rocke DM, Harrison RO: Statistical design of ELISA protocols. J Immunol Method 132:247-254, 1990.
27. Yellin SA, Nguyen D, Quinn JV, Burchard KW, Slotman GJ: Prostacyclin and thromboxane in septic shock: Species differences. Circ Shock 20: 291-297, 1986.
28. 2 using a monoclonal antibody. Prostaglandins 37:577-587, 1989.
29. Samuelsson B, Green K: Endogenous levels of 15-keto-dihydro-prostaglandins in human plasma. Biochem Med 11:298-303, 1974.
30. 2. Biochem et Biophys Acta 750:322-329, 1983.
31. Kramer HJ, Stevens J, Seeger W: Analysis of 2- and 3-series prostanoids by post-HPLC ELISA. Anal Biochem 214:535-543, 1993.